Tellbio
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
123 Crane Neck St, West Newbury, Massach...Phone Number
(781) 249-9550Website
www.tellbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Tellbio
TellBio Inc. is a development stage biotechnology company with the goal to revolutionize the detection and treatment of cancer through its unique and proprietary circulating tumor cells (CTCs) technology and complementary therapeutics platform, TellDx and TellRx, respectively. TellBios vision is to free patients and their families from the tyranny of cancer via both its TellDx and TellRx platforms.Explore more
Tellbio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tellbio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Tellbio, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Tellbio is spiking on competitors!
Click to see if Tellbio had a recent Job posting/layoffs
Earning: See what the market has to say on Tellbio recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Tellbio
Product Launch: Get notified when Tellbio launches new products
Funding: Get notified immidiatlly once Tellbio has new funding data
Check if Tellbio has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Tellbio
Find more new buyers
Compare Similar Companies to Tellbio
Compare insights from companies similar to Tellbio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Tellbio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Tellbio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Tellbio.
Tellbio financials insights
Gather financial insights about Tellbio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$5M
Tellbio Tech Stack
A closer look at the technologies used by Tellbio
See more technologies
Most Recent Scoops
Project
A high-level source in operations has indicated that the organization is planning to release a request for proposal (RFP) for initiatives related to prequalification software within the next three months.
Software
Project
A high-level source in operations has indicated that the organization is planning to release a request for proposal (RFP) for initiatives related to building management software within the next three to six months. Annie Partisano currently serves as Head Senior VP, Operations.
Software, Facilities Management
Project
A high-level source in operations has indicated that the organization has completed initiatives related to capacity planning within the last nine months. Annie Partisano currently serves as Head Senior VP, Operations.
Capacity Planning
Project
A high-level source in operations has indicated that the organization is planning to release a request for proposal (RFP) for initiatives related to property operations & management within the next three months. Annie Partisano currently serves as Head Senior VP, Operations.
Facilities Management
Project
Safety
Tellbio News & Media
Circulating Tumor Cells Isolated with Unique TellDx Technology May Help Predict Response to Therapy in Patients with Progressive Metastatic Breast Cancer
-- CTCs isolated with TellDx leveraged to assess sensitivity and potential clinical benefit from an alternative tolerable therapeutic option in a select cohort of patients with metastatic breast cancer -- -- CTCs isolated with TellDx provide mechanistic insights into the role of ESR1 mutations on response to abemaciclib --Reduction in Circulating Tumor Cells (CTC), Enriched by TellBio Platform, with Novel Dual-Cadherin Antibody (23C6) Results in Significant Metastasis Suppression
-- TellDx CTC System can be leveraged to monitor efficacy of novel therapeutic agents—Circulating Tumor Cell (CTC) Isolation with TellDx Technology Could Inform Personalized Drug Treatment in Prostate Cancer
-- Single-cell proteomics can elucidate kinase activity in prostate cancer models -- -- Kinase activity in bone metastases and epithelial circulating tumor cells is elevated --
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tellbio
Sign Up For FreeTo access detailed company insights
TellBio Inc. is a development stage biotechnology company with the goal to revolutionize the detection and treatment of cancer through its unique and proprietary circulating tumor cells (CTCs) technology and complementary therapeutics platform, TellDx and TellRx, respectively. TellBios vision is to free patients and their families from the tyranny... Read More
